Glycopyrronium Tosylate for Excessive Sweating

Glycopyrronium tosylate is a prescription topical anticholinergic medication approved in the United States for treating primary axillary hyperhidrosis, the medical term for excessive underarm sweating that is not caused by another condition or medication. Sold under the brand name Qbrexza, it comes as a pre-moistened cloth that you wipe across your underarms once daily. The drug was approved by the U.S. FDA in June 2018 for patients aged nine and older, making it the first topical prescription anticholinergic specifically cleared for this use.¹

Why Excessive Sweating Happens

Hyperhidrosis affects a significant number of people and can be genuinely disabling in social and professional settings. The condition is not caused by overactive sweat glands themselves. Instead, it stems from a problem in how the central nervous system regulates sweat secretion. The brain sends signals through the autonomic nervous system that tell sweat glands to turn on, and in people with hyperhidrosis, those signals are dialed up too high. This can involve an overactive sympathetic nervous system or abnormal central processing of emotions, but the glands themselves are structurally normal.²

That distinction matters because it explains why a drug applied to the skin can work: you do not need to fix the glands or the brain. You just need to intercept the signal at the point where it reaches the gland. That is exactly what glycopyrronium tosylate does.

How It Blocks Sweating

Your sweat glands activate when a chemical messenger called acetylcholine lands on receptors sitting on those glands. Glycopyrronium tosylate works by competitively blocking those receptors, called muscarinic receptors, on the eccrine sweat glands in your underarms.³ When the drug is sitting on those receptors, the acetylcholine signal cannot get through, and the gland stays quiet.

Because it is applied directly to the skin rather than swallowed as a pill, very little of the drug gets into your bloodstream. Pharmacokinetic studies found the estimated bioavailability was only about 0.5% in people who absorbed the drug, and there was no buildup with repeated daily use.⁴ That low absorption rate is why topical application causes far fewer of the classic anticholinergic side effects you would see with an oral version of the same type of drug, such as a dry mouth or constipation.

How Well It Works

The two pivotal trials behind the FDA approval, called ATMOS-1 and ATMOS-2, enrolled adults and adolescents with moderate-to-severe axillary hyperhidrosis. At four weeks, pooled results showed that about 60% of patients using the glycopyrronium tosylate cloth achieved a meaningful reduction in sweating severity, compared to roughly 28% of those using a placebo cloth. Gravimetric measurements, which weigh the actual sweat collected from a pad, showed a larger reduction in sweat output in the treated group as well.⁵

Four weeks is relatively short, so the question of durability matters. A 44-week open-label extension study followed patients who continued using the cloths. Improvements held up throughout the trial. By week 44, about 63% of participants had achieved at least a two-grade improvement on a standard disease-severity scale, and measured sweat production had dropped by roughly 71% from their original baseline.⁶ Other data suggest improvements can be maintained for up to 48 weeks.⁷

These are encouraging numbers, but they come with the usual caveat of clinical trials: participants are selected, monitored, and motivated in ways that real-world patients sometimes are not. Still, the consistency between the controlled trials and the longer open-label period is reassuring.

Side Effects and Safety Profile

The drug is generally well tolerated. Most adverse events reported in the trials were mild to moderate.⁸ Local skin reactions at the application site, like dryness or mild irritation, are the most common complaint. Because the drug blocks acetylcholine receptors and a small amount does get absorbed, some users experience anticholinergic effects beyond the underarms. Dry mouth is the most frequently reported systemic side effect, though it tends to be mild.

The side effect that catches the most attention is accidental eye exposure. If you touch your eyes after handling the medicated cloth, the drug can cause your pupils to dilate, leading to blurry vision. A multicenter analysis of patients who experienced this found that blurry vision was the most commonly reported symptom, affecting about 69% of those cases, followed by eye dryness and headache.⁹ The effect is temporary but unpleasant and can be alarming if you do not know what caused it. Washing your hands thoroughly after using the cloth is the single most important practical step to avoid this.

When Proper Use Goes Wrong

The cloth format is convenient but not foolproof. A case report described a young woman who came to an emergency department after four days of worsening nearsightedness, dry mouth, inability to sweat, and difficulty urinating. The cause turned out to be overuse of the glycopyrronium tosylate cloths.¹⁰ That cluster of symptoms is a textbook anticholinergic toxicity pattern. It resolved once she stopped using the product excessively, but the case illustrates that “topical” does not mean “harmless if you use too much.” The approved dose is one cloth applied to both underarms once a day. Using more than that, or wiping larger areas of the body, raises the risk of systemic absorption and the whole spectrum of anticholinergic side effects.

Use in Children and Adolescents

The FDA approval covers patients aged nine and older, and the pediatric data are genuinely encouraging for parents worried about their child’s sweating. Post hoc analyses of the phase 3 trials found that children and adolescents responded comparably to adults: improvements in sweating severity, disease-severity scores, and quality-of-life measures were similar, and the effect was consistently better than placebo.¹¹

In the longer-term open-label extension, the safety profile in pediatric patients looked similar to the adult data. More than 95% of treatment-related adverse events were mild or moderate, no serious adverse events occurred in the pediatric group, and most anticholinergic side effects resolved within a week without needing a dose change. Only one out of 38 pediatric patients discontinued due to side effects. About a third of pediatric participants developed local skin reactions, though again, most were mild.¹² For a condition that can be socially devastating during adolescence, having an FDA-cleared topical option with a clean safety record in that age group is meaningful.

How It Compares to Other Treatments

Excessive sweating has a range of treatments, and glycopyrronium tosylate occupies a specific niche. Over-the-counter aluminum-based antiperspirants are the cheapest first step but do not work well enough for many people with moderate-to-severe hyperhidrosis. Prescription-strength aluminum chloride is the usual next step but can cause significant skin irritation. Botulinum toxin injections are highly effective but require office visits, are painful, and wear off every several months.

Head-to-head comparisons are limited, but one study found that topical glycopyrrolate at a 2% concentration produced results statistically comparable to botulinum toxin injections for underarm sweating, while a 1% concentration was less effective than botulinum toxin.¹³ A broader review comparing different anticholinergic formulations found that the quality-of-life improvements with topical glycopyrrolate were larger than those seen with topical or oral oxybutynin, though disease-severity scale improvements varied depending on which scale was used.¹⁴ The takeaway is that all of these anticholinergic options work, but measuring “which is best” depends on whether you prioritize disease severity, quality of life, or a different metric. The convenience advantage of a daily cloth over periodic injections or pills with systemic side effects is hard to quantify in a clinical trial but matters a lot in real life.

Off-Label Use for Facial Sweating

The FDA approval is specifically for underarm sweating, but hyperhidrosis can affect the face, scalp, palms, and feet. Dermatologists have begun using the cloths off-label for other areas, and there are published reports of success. One particularly vivid case described a man with severe craniofacial hyperhidrosis who was desperate about sweating through his upcoming wedding. He wiped his forehead with a glycopyrronium tosylate cloth the night before and did not sweat during the ceremony or reception. He continued using the cloths on his forehead and hairline after showering on an ongoing basis.¹⁵

Off-label use is common in dermatology, but it comes with less data backing it up. The face has thinner skin than the underarms, which could mean higher absorption and a greater risk of the drug reaching the eyes. Anyone considering this should work with a dermatologist who can weigh the benefit against those risks.

The Cost Question

The elephant in the room for many patients is price. Glycopyrronium tosylate is a brand-name medication without a generic equivalent, and the sticker price is high. A cost-effectiveness analysis compared it against prescription aluminum chloride over five years and found that glycopyrronium tosylate produced modestly better outcomes but at a substantially higher cost. The incremental price was about $10,584 more over five years, which translated to roughly $87,000 per additional quality-adjusted life year gained.¹⁶ That figure fell below commonly used cost-effectiveness thresholds in about two-thirds of modeled scenarios, but it still represents real money out of pocket for patients without insurance coverage or with high copays.

Insurance coverage varies widely. Some plans cover it readily with prior authorization; others consider it cosmetic or require documentation that cheaper alternatives have failed first. If cost is a barrier, it is worth asking your dermatologist about manufacturer savings programs, which have historically been available for this product, or about compounded glycopyrrolate solutions that pharmacies can prepare at a fraction of the brand-name price. Compounded versions lack the standardized dosing and FDA oversight of the branded cloth but are widely used in practice.

The Japanese Experience

The drug was developed and approved in the United States, and whether its efficacy holds across different populations is a reasonable question. A randomized, double-blind, vehicle-controlled trial was conducted specifically in Japanese patients with primary axillary hyperhidrosis. While glycopyrronium tosylate had not previously been studied in that population, the trial was designed to evaluate whether the same cloth formulation worked similarly.¹⁷ The study’s existence reflects a broader pattern in dermatology, where skin physiology, sweat gland density, and drug metabolism can differ enough across ethnic groups that regulatory agencies want population-specific data before granting approval in new markets.

Practical Tips for Getting the Most Out of It

If you have a prescription or are considering one, a few practical details make a difference. Apply the cloth at bedtime rather than in the morning. Nighttime application gives the drug hours to bind to receptors while your sweat glands are relatively quiet, and by morning the active ingredient has been absorbed into the skin. Wash your hands immediately and thoroughly with soap and water after applying it. This is not optional advice; it is the primary way to prevent the blurry-vision problem caused by accidentally touching your eyes.

Avoid applying the cloth to broken or irritated skin, and do not use it on areas beyond your underarms unless your dermatologist has specifically directed you to. The one-cloth-per-day dosing limit exists for a reason: exceeding it pushes absorption into territory where systemic anticholinergic effects become more likely. If you develop dry mouth, constipation, difficulty urinating, or blurry vision, those are signs that your body is absorbing more drug than intended, and you should contact your prescriber.

For people who find that the cloth works well but the skin irritation is bothersome, using a gentle, fragrance-free moisturizer on the underarms during the day can help, as long as you apply the medicated cloth to clean, dry skin at night. Mixing the cloth with other underarm products like antiperspirants has not been well studied, so it is best to keep them separated by time if you use both.